Equities
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

JD Health International Inc is an investment holding company primarily engaged in the provision of pharmaceutical and healthcare products, internet healthcare, health management and intelligent healthcare solutions. The Company's businesses primarily include retail pharmacy and healthcare services. The retail pharmacy business is primarily engaged in the sales of pharmaceuticals and health products, as well as medical devices through online marketplace and on-demand retail channels. The healthcare services business is primarily engaged in the provision of healthcare services through Internet hospitals and large language models. The Company is also engaged in the provision of online marketing services such as advertising. The Company primarily conducts its businesses in the domestic market.

  • Revenue in HKD (TTM)73.27bn
  • Net income in HKD5.31bn
  • Incorporated2018
  • Employees4.57k
  • Location
    JD Health International Inc8th Floor, Building C No. 18 Kechuang 11, Yizhuang Economic and TechnologicalDevelopment Zone, Daxing DistrictBEIJING 101111ChinaCHN
  • Websitehttps://ir.jdhealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.